Genetic testing for kids with cancer or before transplant
Part of Cancer clinical trials.
This study looks at how genetic testing can help tailor cancer treatment for children and young adults. It is for patients newly diagnosed with cancer or those preparing for a bone marrow transplant for a non-cancer condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 26 years old or younger.
- You must have a new cancer diagnosis and be about to start treatment, or you are preparing for a bone marrow transplant for a non-cancer condition.
- You cannot have already started cancer treatment (except for certain spinal fluid treatments).
- You cannot have had a bone marrow transplant in the past, or be planning one as part of your first cancer treatment.
- You cannot have had an organ or tissue transplant before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a new system that connects genetic test results to your medical records can help reduce healthcare gaps for people with advanced cancer. It may help your doctor better personalize your treatment.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study tests a new way to offer genetic testing to young adults (ages 18-39) who have or had cancer. The goal is to make it easier for you to learn if you have inherited gene changes that could affect your cancer and your family's health.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.